Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancerIfeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, et al.
JCO Precision Oncology|November 9, 2023
Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic CancerIfeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancerSiddharth Mehra, Supriya Srinivasan, Sudhakar Jinka, et al.
Oncogene|June 14, 2022
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancerJashodeep Datta, Anna Bianchi, Iago De Castro Silva, et al.
Pancreas|December 20, 2019
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine TumorsJames R Howe, Nipun B Merchant, Claudius Conrad, et al.
Annals of Surgery|August 8, 2012
Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patientsSyed A Ahmad, Michael J Edwards, Jeffrey M Sutton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancerH Charles Manning, Nipun B Merchant, A Coe Foutch, et al.
Journal of Surgical Oncology|August 21, 2024
Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional analysisHaleh Amirian, Erin Dickey, Ifeanyichukwu Ogobuiro, et al.
Annals of Surgery|July 9, 2019
Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic CancerFrancis I Macedo, Emily Ryon, Shishir K Maithel, et al.
Pageof 19